• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌-胆管细胞癌混合型的临床病理研究:重点探讨中间细胞形态。

Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.

机构信息

Department of Pathology, Chonbuk National University Medical School, Institute for Medical Sciences, Research Institute of Clinical Medicine, Jeonju, Korea.

出版信息

J Korean Med Sci. 2011 Aug;26(8):1023-30. doi: 10.3346/jkms.2011.26.8.1023. Epub 2011 Jul 27.

DOI:10.3346/jkms.2011.26.8.1023
PMID:21860552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3154337/
Abstract

Combined hepatocellular carcinoma and cholangiocarcinoma (combined HCC-CC) is a rare subtype of primary liver cancer. We investigated the histopathologic features of transitional or intermediate areas in 21 combined HCC-CCs and immunophenotypes using different hepatic progenitor cell markers (CK7, CK19, c-kit, NCAM, and EpCAM). Major histologic findings of transitional or intermediate areas of 21 combined HCC-CCs included strands/trabeculae of small, uniform, oval-shaped cells with scant cytoplasm and hyperchromatic nuclei embedded within an abundant stroma, small cells with an antler-like anastomosing pattern, and solid nests of intermediate hepatocyte-like cells surrounded by small cells in periphery, in order of frequency. The intermediate area of one tumor was composed predominantly of spindle cells arranged in short fascicles. Immunophenotype of tumor cells with intermediate morphology suggested a progenitor cell origin for this tumor. Clinical findings of combined HCC-CC showed a closer resemblance with those of HCC than those of CC. In univariate analysis, tumor size, TNM stage, and serum alpha-fetoprotein levels showed a significant association with poor patient survival. Serum alpha-fetoprotein level was an independent prognostic indicator in multivariate analysis. In conclusion, an awareness of the clinicopathologic features, specifically the various morphologic features of intermediate areas in this tumor, is essential for prevention of potential misdiagnosis as another tumor.

摘要

肝细胞癌-胆管细胞癌(combined HCC-CC)是一种罕见的原发性肝癌亚型。我们研究了 21 例 combined HCC-CC 中过渡区或中间区的组织病理学特征,并使用不同的肝祖细胞标志物(CK7、CK19、c-kit、NCAM 和 EpCAM)检测其免疫表型。21 例 combined HCC-CC 过渡区或中间区的主要组织学发现包括:小而均匀的椭圆形细胞条索/小梁,细胞胞质稀少,核深染,嵌入丰富的基质中;鹿角样吻合的小细胞;周围为小细胞的中等大小肝细胞样细胞的实性巢,依次为频率。一个肿瘤的中间区主要由短束排列的梭形细胞组成。具有中间形态的肿瘤细胞的免疫表型提示该肿瘤来源于祖细胞。combined HCC-CC 的临床发现与 HCC 更相似,而与 CC 不相似。单因素分析显示,肿瘤大小、TNM 分期和血清甲胎蛋白水平与患者生存不良显著相关。在多因素分析中,血清甲胎蛋白水平是独立的预后指标。总之,了解该肿瘤的临床病理特征,特别是中间区的各种形态特征,对于预防潜在的误诊为另一种肿瘤至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac16/3154337/fb1ebc7734a1/jkms-26-1023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac16/3154337/5bfed1f55c15/jkms-26-1023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac16/3154337/fb1ebc7734a1/jkms-26-1023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac16/3154337/5bfed1f55c15/jkms-26-1023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac16/3154337/fb1ebc7734a1/jkms-26-1023-g002.jpg

相似文献

1
Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.肝细胞癌-胆管细胞癌混合型的临床病理研究:重点探讨中间细胞形态。
J Korean Med Sci. 2011 Aug;26(8):1023-30. doi: 10.3346/jkms.2011.26.8.1023. Epub 2011 Jul 27.
2
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.背景:祖细胞激活与肝细胞癌-胆管细胞癌联合切除术后复发有关。
Hepatology. 2012 Nov;56(5):1804-16. doi: 10.1002/hep.25874. Epub 2012 Jun 25.
3
Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.源自肝祖细胞的肝内胆管癌:免疫组织化学及双荧光免疫染色证据
Histopathology. 2008 Jan;52(2):224-32. doi: 10.1111/j.1365-2559.2007.02929.x.
4
Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.具有中间型(肝细胞-胆管细胞)表型的原发性肝癌。
J Hepatol. 2004 Feb;40(2):298-304. doi: 10.1016/j.jhep.2003.10.023.
5
[Clinicopathologic features of combined hepatic carcinoma].[联合型肝癌的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2013 Dec;42(12):824-8.
6
[Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].[具有干细胞特征的肝细胞-胆管细胞癌(胆管细胞样型):26例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2016 Mar;45(3):175-9. doi: 10.3760/cma.j.issn.0529-5807.2016.03.007.
7
Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.探究肝祖细胞相关特征:乙型肝炎相关肝细胞-胆管细胞癌的组织学异质性。
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):873-879. doi: 10.1007/s11596-017-1820-y. Epub 2017 Dec 21.
8
Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.在肝细胞癌合并胆管癌中,肝细胞癌成分和胆管癌成分同时出现肝细胞癌和胆管癌两种表型的表达。
Med Mol Morphol. 2012 Dec;45(1):7-13. doi: 10.1007/s00795-010-0534-z. Epub 2012 Mar 20.
9
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.肝细胞-胆管细胞癌合并症:一项组织病理学、免疫组织化学及原位杂交研究
Am J Surg Pathol. 2002 Aug;26(8):989-97. doi: 10.1097/00000478-200208000-00003.
10
Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.根据最新的世界卫生组织分类,对肝细胞癌-胆管细胞癌联合癌进行临床病理分析。
Am J Surg Pathol. 2013 Apr;37(4):496-505. doi: 10.1097/PAS.0b013e31827332b0.

引用本文的文献

1
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma.具有肝细胞癌和胆管细胞癌特征的临床病理特征和预后。
BMC Cancer. 2024 Oct 7;24(1):1232. doi: 10.1186/s12885-024-12970-8.
2
Current advances and future directions in combined hepatocellular and cholangiocarcinoma.肝细胞癌合并胆管癌的当前进展与未来方向
Gastroenterol Rep (Oxf). 2024 Apr 15;12:goae031. doi: 10.1093/gastro/goae031. eCollection 2024.
3
Budd Chiari Syndrome and Intrahepatic Cholangiocarcinoma, An Unusual Combination: Case Report and Review of the Literature.

本文引用的文献

1
Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.肿瘤内中性粒细胞:肝癌切除术后的预后不良因素。
J Hepatol. 2011 Mar;54(3):497-505. doi: 10.1016/j.jhep.2010.07.044. Epub 2010 Oct 1.
2
A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry.免疫组织化学证实一例产生粒细胞集落刺激因子的肝细胞癌。
J Korean Med Sci. 2010 Mar;25(3):476-80. doi: 10.3346/jkms.2010.25.3.476. Epub 2010 Feb 17.
3
Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
布加综合征与肝内胆管细胞癌的不常见组合:病例报告及文献复习。
Perm J. 2020 Nov;24:1-3. doi: 10.7812/TPP/19.204.
4
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素:倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
5
Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types.影像组学可预测不同病理类型原发性肝癌患者的术后生存率。
Ann Transl Med. 2020 Jul;8(13):820. doi: 10.21037/atm-19-4668.
6
Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.联合肝细胞癌(cHCC)患者肝切除术后总生存和无复发生存的综合列线图预测模型。
Aging (Albany NY). 2020 Aug 13;12(15):15334-15358. doi: 10.18632/aging.103577.
7
Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.肝细胞-胆管细胞癌合并症:手术后临床病理特征分析
Medicine (Baltimore). 2019 Sep;98(38):e17102. doi: 10.1097/MD.0000000000017102.
8
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.MRI 特征在肝细胞癌-胆管细胞癌与肿块型肝内胆管细胞癌的对比。
Cancer Imaging. 2018 Feb 27;18(1):8. doi: 10.1186/s40644-018-0142-z.
9
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.cHCC-CCA:具有肝细胞和胆管细胞分化的原发性肝癌的共识术语。
Hepatology. 2018 Jul;68(1):113-126. doi: 10.1002/hep.29789. Epub 2018 May 9.
10
The potential role of liver stem cells in initiation of primary liver cancer.肝干细胞在原发性肝癌起始过程中的潜在作用。
Hepatol Int. 2016 Nov;10(6):893-901. doi: 10.1007/s12072-016-9730-9. Epub 2016 May 2.
根治性切除术后联合肝细胞癌和胆管细胞癌的长期预后与肝细胞癌和胆管细胞癌的比较。
J Clin Gastroenterol. 2011 Jan;45(1):69-75. doi: 10.1097/MCG.0b013e3181ce5dfa.
4
Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.肝内胆管癌及肝细胞-胆管细胞癌合并症:西方经验
Ann Surg Oncol. 2008 Jul;15(7):1880-90. doi: 10.1245/s10434-008-9933-y. Epub 2008 Apr 29.
5
Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.源自肝祖细胞的肝内胆管癌:免疫组织化学及双荧光免疫染色证据
Histopathology. 2008 Jan;52(2):224-32. doi: 10.1111/j.1365-2559.2007.02929.x.
6
Human hepatic stem cells from fetal and postnatal donors.来自胎儿和产后供体的人肝干细胞。
J Exp Med. 2007 Aug 6;204(8):1973-87. doi: 10.1084/jem.20061603. Epub 2007 Jul 30.
7
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.15例肝细胞癌合并胆管癌患者的临床病理特征
Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.
8
Hepatic progenitor cells in human liver tumor development.人类肝脏肿瘤发生中的肝祖细胞
World J Gastroenterol. 2006 Oct 21;12(39):6261-5. doi: 10.3748/wjg.v12.i39.6261.
9
Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence.具有肝前体细胞起源的肝细胞癌和肝内胆管细胞癌联合发生的潜能:免疫组织化学证据。
Hepatol Res. 2005 May;32(1):52-7. doi: 10.1016/j.hepres.2005.01.012.
10
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.肝细胞胆管癌的临床病理特征及预后
Am J Surg. 2005 Jan;189(1):120-5. doi: 10.1016/j.amjsurg.2004.03.018.